Solid QoQ momentum in the US with what appears to be more to come with further accounts and staff to be added.
RoW is lagging but it is evident that the majority of PNV resources are being thrown at taking as much market share as possible in the US.
What is interesting is that sales staff can't keep up with the novel indications surgeons are using BTM for and in turn they are requiring further training themselves. This is what you want to see.
Solid QoQ momentum in the US with what appears to be more to...
-
- There are more pages in this discussion • 149 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.42 |
Change
-0.010(0.41%) |
Mkt cap ! $1.670B | |||
| Open | High | Low | Value | Volume |
| $2.42 | $2.43 | $2.38 | $2.583M | 1.073M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 15691 | $2.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.42 | 163 | 1 |
View Market Depth
| Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
| PNV (ASX) Chart |